{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:16:29Z","timestamp":1782562589998,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.hpb.2026.01.015","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:04:42Z","timestamp":1770077082000},"page":"700-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neoadjuvant therapy in gall bladder cancer improves resectability and survival: a prospective study"],"prefix":"10.1016","volume":"28","author":[{"given":"Anupam","family":"Lahiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchita","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaifali","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Assif Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prerna","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-3261","authenticated-orcid":false,"given":"Varun","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskaran","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2026.01.015_bib1","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","volume":"6","author":"Hundal","year":"2014","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.hpb.2026.01.015_bib2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/SLA.0b013e31806beec2","article-title":"Gallbladder cancer: the role of laparoscopy and radical resection","volume":"245","author":"Shih","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2026.01.015_bib3","article-title":"Gemcitabine, cisplatin, nab-paclitaxel: The effectiveness of this regimen for gall bladder cancer","volume":"41:","author":"Chaugule","year":"2023","journal-title":"J Clin Orthod"},{"key":"10.1016\/j.hpb.2026.01.015_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5005\/jp-journals-10018-1348","article-title":"Neoadjuvant chemotherapy for advanced gallbladder cancer: do we have enough evidence? A systematic review","volume":"11","author":"Naveed","year":"2021","journal-title":"Euroasian J Hepatogastroenterol"},{"issue":"10","key":"10.1016\/j.hpb.2026.01.015_bib5","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2217\/fon.14.308","article-title":"Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer","volume":"11","author":"Sirohi","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.hpb.2026.01.015_bib6","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1097\/MS9.0000000000000699","article-title":"Resectability and prognosis of gallbladder cancer: a cross-sectional study of 100 cases from a tertiary care centre of Eastern Nepal","volume":"85","author":"Pandit","year":"2023","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.hpb.2026.01.015_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.47717\/turkjsurg.2022.5861","article-title":"Long-term results and prognostic factors after surgical treatment for gallbladder cancer","volume":"38","author":"Uzun","year":"2022","journal-title":"Turk J Surg"},{"key":"10.1016\/j.hpb.2026.01.015_bib8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4240\/wjgs.v16.i1.95","article-title":"Post-operative morbidity after neoadjuvant chemotherapy and resection for gallbladder cancer: a national surgical quality improvement program analysis","volume":"16","author":"Kim","year":"2024","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.hpb.2026.01.015_bib9","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.hpb.2018.03.008","article-title":"Outcome of neoadjuvant chemotherapy in \"locally advanced\/borderline resectable\" gallbladder cancer: the need to define indications","volume":"20","author":"Chaudhari","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2026.01.015_bib10","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.ejso.2020.04.015","article-title":"18-FDG PET-CT should be included in preoperative staging of gall bladder cancer","volume":"46","author":"Goel","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2026.01.015_bib11","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s12664-021-01182-8","article-title":"Combination of portal vein embolization and neoadjuvant chemotherapy for locally advanced gallbladder cancer requiring extended hepatectomy - a novel approach","volume":"40","author":"Singh","year":"2021","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.hpb.2026.01.015_bib12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1007\/s12029-023-00914-7","article-title":"Interaortocaval lymph node metastasis in gall bladder cancer: is it regional node or metastatic disease?","volume":"54","author":"Aggarwal","year":"2023","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.hpb.2026.01.015_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jjco\/hyv148","article-title":"FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients","volume":"46","author":"Dodagoudar","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.hpb.2026.01.015_bib14","article-title":"Predicting clinical benefit response after neoadjuvant chemotherapy in locally advanced gallbladder cancer: retrospective analysis","volume":"9:zraf077","author":"Patkar","year":"2025","journal-title":"BJS Open"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X2600016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X2600016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:54:08Z","timestamp":1777672448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X2600016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1365182X2600016X"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2026.01.015","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant therapy in gall bladder cancer improves resectability and survival: a prospective study","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2026.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}